Novo Nordisk said it would invest more than $6 billion to boost production capacity for its blockbuster Wegovy obesity drug.

Novo Nordisk said it would invest more than $6 billion to boost production capacity for its blockbuster Wegovy obesity drug. https://ift.tt/N5or7qa